e-learning
resources
Munich 2006
Sunday 03.09.2006
Molecular pathology: an approach to lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
R. P. Baughman (Cincinnati, United States of America)
Source:
Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Session:
Molecular pathology: an approach to lung diseases
Session type:
Symposium
Number:
917
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. P. Baughman (Cincinnati, United States of America). Bronchoalveolar lavage: how can we use it more effectively to define pathology?. Annual Congress 2006 - Molecular pathology: an approach to lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
What does bronchoalveolar lavage add to cryobiopsy in interstitial lung disease?
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Bronchoalveolar lavage
Source: Eur Respir Mon; 2010: 48: 59–72
Year: 2010
Bronchoalveolar lavage: did it fulfill its promises?
Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Year: 2005
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Bronchoalveolar lavage in children with diffuse lung disease
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008
Bronchoalveolar lavage (BAL) to monitor disease progression
Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Year: 2012
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema
Source: Eur Respir J 2005; 25: 275-281
Year: 2005
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Bronchoalveolar lavage in patients with fibrotic ILDs: is it helpful?
Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases
Year: 2019
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2001; 18: Suppl. 33, 507s
Year: 2001
Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept